This resulted in reduced growth of CD73+ tumors, accompanied by higher levels of granzyme B. Furthermore, CD73-CAR-NK cells led to a prolonged arrest of tumor growth, persisting for nearly 50 days post-tumor implantation, unlike the other treatment groups. The gene discussed is GZMB; the disease is neoplasm.